Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Rockwell Medical Community
NasdaqCM:RMTI Community
3
Narratives
written by author
0
Comments
on narratives written by author
11
Fair Values set
on narratives written by author
Community Investing Ideas
Rockwell Medical
Popular
Undervalued
Overvalued
Rockwell Medical
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Dialysis Loss Will Squeeze Margins Yet Yield Cautious Relief
Key Takeaways Advances in alternative and at-home dialysis technologies by competitors threaten to erode Rockwell Medical's market share and limit future revenue growth. Industry consolidation and healthcare cost pressures risk driving down prices and reimbursement rates, making sustainable profitability more challenging for Rockwell Medical.
View narrative
US$3.00
FV
65.0% undervalued
intrinsic discount
-6.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Rockwell Medical
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging And Home Care Trends Will Raise Demand Amid Risks
Key Takeaways Strong customer diversification, expanding industry contracts, and competitive gains are poised to drive above-expected revenue growth and significant margin expansion. Leading market position and scalable logistics infrastructure position Rockwell to benefit from industry shifts and unlock recurring, higher-margin future revenue streams.
View narrative
US$5.00
FV
79.0% undervalued
intrinsic discount
-13.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Rockwell Medical
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Dialysis Demand Will Grow Despite Margin And Market Challenges
Key Takeaways Increased demand for dialysis solutions and successful long-term contracts drive stable growth and revenue visibility, especially as the company enters new and underserved markets. Operational improvements and a strong reputation enhance margins and market share, with expanded access and customer acquisitions supporting further revenue gains.
View narrative
US$4.00
FV
73.8% undervalued
intrinsic discount
-6.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
RMTI
RMTI
Rockwell Medical
Your Fair Value
US$
Current Price
US$1.05
73.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-33m
94m
2015
2018
2021
2024
2025
2027
2030
Revenue US$68.5m
Earnings US$9.8m
Advanced
Set Fair Value